<DOC>
	<DOCNO>NCT02170675</DOCNO>
	<brief_summary>To investigate whether extent P-glycoprotein ( P-gp ) inhibitor ketoconazole affect plasma exposure dabigatran .</brief_summary>
	<brief_title>Relative Bioavailability Single Doses Dabigatran Etexilate When Administered Alone Combination With Single Dose Ketoconazole Combination With q.d . Ketoconazole Steady State Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Healthy male female accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test 2 . Age ≥21 ≤50 year 3 . BMI range ≥18.5 ≤29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance GCP local legislation . 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Surgery gastrointestinal tract ( except appendectomy ) 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackout . 7 . Chronic relevant acute infection 8 . History relevant allergy/hypersensitivity ( include allergy drug excipients ) 9 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial , intake drug might reasonably influence result trial within four week prior administration trial ( e.g . Pgp inducer ) 10 . Participation another trial investigational drug within two month prior administration trial 11 . Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) 12 . Alcohol abuse ( 60 g/day ) 13 . Drug abuse 14 . Blood donation ( 100 mL within four week prior administration trial ) 15 . Excessive physical activity ( within one week prior administration trial ) 16 . Any laboratory value outside reference range clinical relevance 17 . Inability comply dietary regimen trial site Exclusion criterion specific study : 18 . Intake medication , influence blood clotting , acetylsalicylic acid oral vitamin K antagonists For female subject : 19 . Pregnancy / positive pregnancy test , plan become pregnant study within 1 month study completion 20 . No adequate contraception study 1 month study completion , i.e . implant , injectables , combine oral contraceptive , IUD [ intrauterine device ] , sexual abstinence ( least 1 month prior enrolment ) , surgical sterilisation ( incl . hysterectomy ) . Females , surgically sterile ask additionally use barrier contraception method ( e.g . condom , diaphragm spermicide ) 21 . Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>